Behavioral and biochemical studies in monkeys made hemiparkinsonian by MPTP

Area of Science:

• Neuroscience
• Primate Models
• Neurodegenerative Diseases

Background:

• Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor deficits.
• Animal models are crucial for understanding PD pathogenesis and testing therapies.
• Unilateral models can help elucidate brain lateralization in motor control.

Purpose of the Study:

• To establish a stable, unilateral hemiparkinsonian model in non-human primates.
• To investigate the behavioral and biochemical effects of unilateral N-methyl-4-phenyl-2,3,5,6-tetrahydropyridine (MPTP) administration.
• To assess motor function recovery with and without levodopa treatment.

Main Methods:

• Monkeys were trained to perform a rapid bar-pressing task with either hand.
• Unilateral internal carotid artery injection of MPTP was performed via transfemoral catheterization.
• Behavioral performance (bar-pressing activity) was monitored.
• Striatal dopamine levels were measured biochemically post-mortem.

Main Results:

• MPTP injection induced severe, Parkinson-like motor symptoms unilaterally.
• Bar-pressing activity significantly decreased on the side contralateral to MPTP injection.
• Striatal dopamine levels dropped by 95% in the injected hemisphere.
• The unaffected limb maintained normal motor function and goal-directed behavior.

Conclusions:

• Carotid MPTP injection provides a stable model of hemiparkinsonism.
• This model demonstrates preserved motor function in the unaffected limb.
• The affected limb shows significant motor impairment, responsive to levodopa, highlighting its utility for PD research.